Meenakshi Singh
- Cancer Research top 2%
- Breast Cancer Treatment Studies 10
- Oncology top 2%
- Cancer Cells and Metastasis 7
- HER2/EGFR in Cancer Research 7
- Cancer-related Molecular Pathways 6
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments 12
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 8
- Nutrition and Dietetics top 2%
-
- Estrogen and related hormone effects 10
-
- Breast Lesions and Carcinomas 8
- Co-authors
- Henry J. ThompsonJoseph A. ScimecaKenneth R. ShroyerKimberly K. LeslieDavid HeinzJohn N. McGinleyPeter V. KarpovichKathleen C. Torkko
- Journals
- Applied immunohistochemistry & molecular morphology (7 papers)Carcinogenesis (6 papers)Gynecologic Oncology (6 papers)
- Partner nations
- United StatesIndiaSouth Korea
In The Last Decade
Meenakshi Singh
99 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Cancer Research 740
- Oncology 1.2k
- Obstetrics and Gynecology 334
- Reproductive Medicine 312
- Nutrition and Dietetics 529
Countries citing papers authored by Meenakshi Singh
This map shows the geographic impact of Meenakshi Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meenakshi Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meenakshi Singh more than expected).
Fields of papers citing papers by Meenakshi Singh
This network shows the impact of papers produced by Meenakshi Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meenakshi Singh. The network helps show where Meenakshi Singh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meenakshi Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | Clinical status of potential drugs used for COVID-19 treatment and recent advances in new therapeutics - A review | 2021 | 2 |
| 3 | 2021 | 3 | |
| 4 | Freshwater diatoms as bio-indicators in urban wetlands of central Gujarat, India | 2020 | 5 |
| 5 | 2020 | 1 | |
| 6 | 2019 | 33 | |
| 7 | 2015 | 32 | |
| 8 | 2013 | 46 | |
| 9 | 2011 | 44 | |
| 10 | 2011 | 8 | |
| 11 | Development of a tilting hydraulic flume for runoff and soil loss studies in laboratory | 2010 | 1 |
| 12 | 2008 | 26 | |
| 13 | Effect of Medially Linked and Unlinked Knee Immobilizer on Paraplegic Gait Performance | 2007 | 2 |
| 14 | 2007 | 130 | |
| 15 | 2006 | 179 | |
| 16 | 2006 | 2 | |
| 17 | 2003 | 48 | |
| 18 | 2000 | 91 | |
| 19 | 1995 | 47 | |
| 20 | 1995 | 13 |
About Meenakshi Singh
Meenakshi Singh is a scholar working on Obstetrics and Gynecology, Oncology and Reproductive Medicine, having authored 104 papers that have together received 4.2k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (12 papers), Estrogen and related hormone effects (10 papers), Breast Cancer Treatment Studies (10 papers), Ovarian cancer diagnosis and treatment (8 papers), Breast Lesions and Carcinomas (8 papers), Cancer Cells and Metastasis (7 papers), HER2/EGFR in Cancer Research (7 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Cancer Research (740 citations), Oncology (1.2k citations) and Obstetrics and Gynecology (334 citations). Meenakshi Singh has collaborated with scholars based in United States, India and South Korea. Frequent co-authors include Henry J. Thompson, Joseph A. Scimeca, Kenneth R. Shroyer, Kimberly K. Leslie, David Heinz, John N. McGinley, Peter V. Karpovich, Kathleen C. Torkko, Barbara Tringler and Nicole S. Spoelstra. Their work appears in journals such as Applied immunohistochemistry & molecular morphology, Carcinogenesis, Gynecologic Oncology, Human Pathology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.